Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IgA nephropathy: what's new?

Ronald J Hogg

    Pediatric Nephrology (Berlin, Germany)
    |July 11, 2007
    PubMed
    Summary
    This summary is machine-generated.

    Immunoglobulin A (IgA) nephropathy is a leading cause of progressive kidney disease. Research is evolving to understand genetic factors and identify patients who may benefit from targeted treatments.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hyperuricemia: an unrecognized risk factor for kidney-related sequelae in children with hemolytic uremic syndrome.

    Pediatric nephrology (Berlin, Germany)·2022
    Same author

    Effects of losartan and enalapril on serum uric acid and GFR in children with proteinuria.

    Pediatric nephrology (Berlin, Germany)·2021
    Same author

    Hyperuricosuria, hematuria, and novel bladder images with IgA nephropathy.

    Proceedings (Baylor University. Medical Center)·2021
    Same author

    Changes in PTGS1 and ALOX12 Gene Expression in Peripheral Blood Mononuclear Cells Are Associated with Changes in Arachidonic Acid, Oxylipins, and Oxylipin/Fatty Acid Ratios in Response to Omega-3 Fatty Acid Supplementation.

    PloS one·2015
    Same author

    Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2015
    Same author

    Individual variation in lipidomic profiles of healthy subjects in response to omega-3 Fatty acids.

    PloS one·2013
    Same journal

    Impact of kidney maturation on aminoglycoside exposure in term-born pediatric patients: an in silico study.

    Pediatric nephrology (Berlin, Germany)·2026
    Same journal

    Age at onset and cumulative initial prednisolone dose predict frequent relapses in steroid-sensitive nephrotic syndrome: an individual participant data systematic review and meta-analysis of placebo-controlled RCTs.

    Pediatric nephrology (Berlin, Germany)·2026
    Same journal

    "Life renewed, obstacles persist": a systematic review of qualitative studies on the experiences of children and adolescents post-kidney transplantation.

    Pediatric nephrology (Berlin, Germany)·2026
    Same journal

    Preemptive rituximab for immunosuppressant withdrawal in adolescents and young adults with childhood-onset steroid-dependent nephrotic syndrome.

    Pediatric nephrology (Berlin, Germany)·2026
    Same journal

    Characterizing children with chronic kidney disease and severe proteinuria in the United States: a retrospective analysis using electronic health records.

    Pediatric nephrology (Berlin, Germany)·2026
    Same journal

    New therapeutic hope for rare podocytopathies.

    Pediatric nephrology (Berlin, Germany)·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Immunology
    • Genetics

    Background:

    • Immunoglobulin A (IgA) nephropathy is a significant cause of progressive kidney disease globally.
    • Understanding the genetic basis of abnormal IgA forms is crucial for future therapeutic advancements.

    Discussion:

    • Current treatment options for IgA nephropathy are limited and often lack robust clinical trial data.
    • Identifying prognostic markers is essential to determine which patients require intervention and to avoid unnecessary treatments.

    Key Insights:

    • The role of genetically determined abnormal IgA molecules in disease pathogenesis is an active area of research.
    • Predicting disease progression is key to selecting appropriate candidates for therapy.

    Outlook:

    Related Experiment Videos

    • Future research aims to develop more specific treatments based on a deeper understanding of IgA nephropathy's genetic underpinnings.
    • Further studies are needed to validate treatment strategies, particularly in pediatric populations.